RxSight, Inc. cash flow to debt ratio of -140.50% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

RxSight, Inc.'s free cash flow has increased -13.60% from $-22.39M last year to $-19.34M, signaling increasing performance

RxSight, Inc.'s debt to equity ratio is 0.04, which means that the company's assets are healthy financed, signaling financial stability.

RxSight, Inc.'s debt has decreased relative to shareholder equity from 0.04 last year to 0.04 today, signaling strengthened financials

RxSight, Inc. has a net cash position, so leverage is healthy.

RxSight, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

RxSight, Inc.'s profit margin has decreased (87.55%) in the last year from -19.62% to -36.80%, signaling decreasing performance

RxSight, Inc.'s short-term assets of $287.46M exceed its short-term liabilities of $26.25M

RxSight, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

RxSight, Inc.'s return on equity of -17.35%, is lower than 15.00%, indicating bad performance

RxSight, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

RxSight, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

RxSight, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

RxSight, Inc. has negative free cash flow, indicating cash burn

RxSight, Inc.'s yearly earnings has decreased 41.84% since last year from $-27.45M to $-38.94M, signaling decreasing performance

RxSight, Inc.'s yearly revenue has decreased 3.89% since last year from $139.93M to $134.48M, signaling decreasing performance

ROIC -20.12% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

RxSight, Inc.'s 3-year revenue CAGR of 40.00% is positive, indicating growing revenue over the past 3 years

RxSight, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

RxSight, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

RxSight, Inc. has insufficient data to evaluate this check.

RxSight, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

RxSight, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

RxSight, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

RxSight, Inc. has insufficient data to evaluate this check.

RxSight, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

RxSight, Inc. has a price-to-book ratio of 1.04x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

RxSight, Inc. has a price-to-sales ratio of 2.14x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue